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Chemical esterification of ,-trehalose with two different dipeptide acyl donors, Boc-Phe-
Met-OH and Boc-Gly-Gly-OH, gave a set of products differing in the number and site of sub-
stitution. With both dipeptides 6,6'-diester was isolated as the major product. In the Boc-Phe-
Met-OH line, the dipeptide units in all higher substituted esters were asymmetrically distrib-
uted between the two trehalose rings. In contrast, the first higher substituted Boc-Gly-Gly-OH
derived ester found was the symmetric 2,2',6,6'-tetraester. These four sites remained occupied
in all other isolated products, two asymmetric pentaesters and one symmetric hexaester. The
data presented here show that in addition to sugar hydroxyl group reactivity, the structural pro-
perties of the acylating reagent, in particular its sterical demands, are of the utmost importance
for the distribution and arrangement of acyl moieties around the non-reducing disaccharide core
molecule.
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INTRODUCTION
Peptides of various size as well as peptide mimetics will
comprise a large part of future therapeutics. Promising
lead candidates are already being discovered by modifi-
cation of natural products, phage display and combina-
torial chemistry, and several of them are in clinical tri-
als.1–3 Owing to their small size, peptides are rapidly re-
moved from the circulation by enzymatic degradation
and by rapid filtration in the kidney. Various strategies
for improving peptide half-lives in vivo are currently un-
der investigation, including amino acid backbone modi-
fications, formulation approaches, chemical conjugation
with small molecules, enzyme inhibitors and absorption
enhancers.4 Control of peptide drug release can bring a
number of benefits, including increased pharmacological
efficacy, extended duration of action, greater flexibility
of administrative route and improved targeting of spe-
cific disease sites.
Since carbohydrates play an important role in the
cell function of multicellular organisms and in biological
molecular recognition, one of the main objectives in gly-
cobiology is the investigation of carbohydrate-centered
dendrimers as tools for efficient multivalent presentation
of biological ligands in biospecific recognition, inhibi-
tion and targeting.5–8 Sugars provide abundant reactive
OH groups that can be utilized to attach bioactive pep-
tides through a simple reaction such as esterification. It
can be expected that conjugation of a peptide with a car-
bohydrate molecule will provide a convenient matrix for
stabilization, targeting and controlled release of the par-
ent peptide compound. Despite the ready construction of
ester-carbohydrate linkages, there are few reports on en-
zymatic or chemical syntheses of sugar amino acid es-
ters.9–12 This is all the more surprising given that several
carbohydrate-peptide esters have altered bioactivity13 or
high potential utility as prodrugs, in which the sugar
moiety allows for simultaneous masking of an amino and
a carboxyl group of a peptide.14,15
The specific properties and physiological functions
of trehalose, a non-reducing disaccharide of glucose, and
the expanding trehalose market, prompted chemical and
enzymatic syntheses of trehalose derivatives. This sugar
is widespread throughout the biological world, being
found in organisms such as bacteria, fungi, yeasts, insects,
plants, and many others.16 Besides the essential role of
trehalose in the protection of proteins and membranes
from denaturation caused by different stresses, it was also
shown that 2,3-diesters of trehalose may play an impor-
tant role in determining the outcome of infection with
tubercle bacillus.17 Moreover, it was shown recently that
trehalose, when given orally, can reduce the polygluta-
mine-mediated insoluble protein aggregation in a mouse
model of Huntington’s disease.18 In addition, trehalose
derivatives with guanidino groups attached, are found to
inhibit the Tat-TAR RNA interaction in human cells,
which is essential for HIV-1 replication.19 Taking into
account all the newly discovered potential benefits of
trehalose derivatives, along with the previously known
but still not completely clear role of trehalose in signal-
ing pathways and membrane-protecting mechanisms, there
are many issues to be addressed within this field. One of
the possible approaches is to uncover the susceptibility
of the trehalose active sites (hydroxyl groups) towards
certain reactions or distinct substituents. While enzy-
matic synthesis of sugar amino acid esters can disclose
the acyl donor and acyl acceptor specificity of certain
enzymes,9,11,20 insight into the chemical reactivity of
particular sugar hydroxyl groups can be gained only by
chemically performed esterification.
Following this issue, by using trehalose as a multi-
valent core molecule, in this paper we investigate the pro-
ducts formed by chemical esterification of the disaccha-
ride acceptor with two different dipeptides. As acyl do-
nors, Boc-Phe-Met-OH and Boc-Gly-Gly-OH were chosen
to probe how two structurally very different N-terminally
protected dipeptides will compete for the esterification of
the trehalose hydroxyl groups.
EXPERIMENTAL
General Methods
Melting points were determined on a Tottoli (Büchi) appa-
ratus and were uncorrected. Reactions were monitored by
TLC on Silica Gel 60 F254 plates (Merck; Darmstadt, Ger-
many) applying detection with ninhydrin, chlorine-iodine
reagent or heating with H2SO4.
NMR spectra were recorded on a Bruker AV 600 spec-
trometer operating at 75.47 MHz for 13C and 600.13 MHz
for 1H. Spectra were assigned on the basis of 2D homonu-
clear (COSY) and heteronuclear (HMQC) spectra.
Mass spectra were recorded on a ThermoFinnigan LCQ
Deca ion trap mass spectrometer, operating in Electrospray
Ionization (ESI) mode. The ion source and ion optics of the
instrument were tuned for optimal sensitivity using the au-
totune function of the instrument’s Xcalibur (v. 1.3) software,
by infusing a 50 g/ml solution of compound in methanol
into the ion source of the instrument from a syringe pump
at a flow rate of 10 l/min.
Full scan ESI-MS spectra were recorded in the m/z
range of 150–2300, while the m/z ranges for MS/MS and
MS3 spectra were selected according to the m/z value of the
precursor ions. MS/MS spectra were recorded at both low
and high collision energy settings, the low setting being 25
and the high being 80 units (the units are dimensionless be-
cause they are defined by the software).
Chemicals
General procedure for the synthesis of trehalose-derived di-
peptide esters: ,-trehalose (0.1 mmol) was dissolved in
dry pyridine and treated with the pentachlorophenyl ester of
N-tert-butyloxycarbonyl-L-phenylalanyl-L-methionine (Boc-
-Phe-Met-OPCP) or N-tert-butyloxycarbonyl-glycylglycine
(Boc-Gly-Gly-OPCP) (1 mmol) in the presence of imidazo-
le (5 mmol). The reaction mixture was stirred at room tem-
perature for 24 hours. The solvent was evaporated in vacuo
and the residue was purified by flash chromatography on
silica gel with chloroform-methanol-acetic acid (10:3:0.3)
as the eluent. The fractions enriched with trehalose esters
were collected and further purified by column chromatogra-
phy with toluene-ethanol-ethyl acetate (4:2:1) as the eluent.
6,6'-Di-O-(Boc-Phe-Met-)-,-trehalose (1)
13C NMR (DMSO-d6) /ppm 14.43 (S-CH3, Met), 28.08
(CH3, Boc), 29.39 (C, Met), 30.61 (C, Met), 37.11 (C,
Phe), 50.76 (C, Met), 55.52 (C, Phe), 78.00 (C, Boc),
126.13 (C, Phe), 128.15 (C, Phe), 129.16 (C, Phe),
138.14 (C, Phe), 155.24 (CO, Boc), 171.57, 172.17 (CO,
Phe, Met). 1H NMR (DMSO-d6) /ppm 1.27 (18H, CH3,
Boc), 1.87/1.97 (4H, ,', Met), 2.04 (6H, S-CH3, Met),
2.43/2.53 (4H, ,' Met), 2.71/2.94 (4H, ,', Phe), 4.16 (2H,
, Phe), 4.44 (2H, , Met), 6.93 (2H, NH, Phe), 7.17–7.30
(10H, arom. H, Phe), 8.32 (2H, NH, Met). 1H and 13C NMR
data for the trehalose moiety are presented in Tables I and
II. M.p. 125–131 °C; ESI-MS Calcd. for C50H74N4O19S2
1099.29. Found: (M+Na)+ m/z 1121.2.
2,6,6'-Tri-O-(Boc-Phe-Met-)-,-trehalose (2)
13C NMR (DMSO-d6) /ppm 14.79, 14.97 (S-CH3, Met),
28.29, 28.57 (CH3, Boc), 29.68, 29.82, 29.88, 29.94 (C,
C, Met), 37.53, 37.60 (C, Phe), 51.28, 51.51, 52.01 (C,
Met), 55.99 (C, Phe), 78.46, 78.78 (C, Boc), 126.59, 126.65
(C, Phe), 128.45 (C, Phe), 129.66 (C, Phe), 138.33, 138.65
(C, Phe), 155.51, 155.73 (CO, Boc), 171.90, 171.94, 172.02,
172.17, 172.55, 172.67 (CO, Phe, Met). 1H NMR (DMSO-d6)
/ppm 1.27 (27H, CH3, Boc), 1.91/2.02, 1.92/2.16 (6H, ,',
Met), 2.04, 2.05 (9H, S-CH3, Met), 2.32/2.40, 2.47/2.55
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(6H, ,' Met), 2.76/2.96 (6H, ,', Phe), 4.21 (3H, , Phe),
4.49 (3H, , Met), 6.81 (3H, NH, Phe), 7.18–7.26 (15H,
arom. H, Phe), 8.24 (3H, NH, Met). 1H and 13C NMR data
for the trehalose moiety are presented in Tables I and II.
M.p. 105–115 °C; ESI-MS Calcd. for C69H100N6O23S3
1477.78. Found: (M+Na)+ m/z 1499.2.
Tri-O-(Boc-Phe-Met-)-,-trehalose (3)
13C NMR (DMSO-d6) /ppm 14.29, 14.43, 14.57 (S-CH3,
Met), 28.03 (CH3, Boc), 29.21, 30.65 (C, C, Met), 37.14
(C, Phe), 50.67, 50.80 (C, Met), 55.41 (C, Phe), 77.97
(C, Boc), 126.05 (C, Phe), 127.89 (C, Phe), 129.11 (C,
Phe), 137.77, 138.06 (C, Phe), 155.14, (CO, Boc), 171.42,
171.98 (CO, Phe, Met). 1H NMR (DMSO-d6) /ppm 1.29
(27H, CH3, Boc), 1.82/1.90, 1.90/2.01 (6H, ,', Met),
2.02, 2.04 (9H, S-CH3, Met), 2.30/2.39, 2.45/2.54 (6H, ,'
Met), 2.76/2.96 (6H, ,', Phe), 4.20 (3H, , Phe), 4.44
(3H, , Met), 6.80 (3H, NH, Phe), 7.19–7.25 (15H, arom.
H, Phe), 8.23 (3H, NH, Met). M.p. 100–108 °C; ESI-MS
Calcd. for C69H100N6O23S3 1477.78. Found: (M+Na)+ m/z
1499.2.
Tetra-O-(Boc-Phe-Met-)-,-trehalose (4)
13C NMR (DMSO-d6) /ppm 14.31, 14.46, (S-CH3, Met),
27.77, 28.06 (CH3, Boc), 29.24, 30.55, 30.87, 31.25 (C,
C, Met), 37.14 (C, Phe), 50.33, 50.57, 50.82, 51.05 (C,
Met), 55.44 (C, Phe), 63.10, 63.56 (C6,6',Tre), 77.99 (C,
Boc), 90.51, 91.15, 91.36, 91.43, 93.44, 94.05, 94.35, 94.42,
94.71 (C1,1', Tre), 126.10 (C, Phe), 127.92 (C, Phe),
129.13 (C, Phe), 137.78, 138.11 (C, Phe), 154.96, 155.18,
156.56 (CO, Boc), 170.98, 171.33, 171.44, 171.71, 171.95,
172.11 (CO, Phe, Met). 1H NMR (DMSO-d6) /ppm 1.29
(36H, CH3, Boc), 1.8–2.1 (8H, ,', Met), 2.0–2.07 (12H,
S-CH3, Met), 2.4–2.6 (8H, ,' Met), 2.72/2.96 (8H, ,',
Phe), 3.55, 3.75, 3.85 (5H, Tre), 4.23 (4H, , Phe), 4.47
(4H, , Met), 4.5–5.6 (9H, Tre), 6.8–7.1 (4H, NH, Phe),
7.18–7.28 (20H, arom. H, Phe), 8.35 (4H, NH, Met). M.p.
107–115 °C; ESI-MS Calcd. for C88H126N8O27S4 1856.27.
Found: (M+Na)+ m/z 1877.4.
Penta-O-(Boc-Phe-Met-)-,-trehalose (5)
13C NMR (DMSO-d6) /ppm 14.33, 14.49, 14.64 (S-CH3,
Met), 27.84, 28.13, (CH3, Boc), 29.25, 29.41, 30.64 (C, C,
Met), 37.15 (C, Phe), 50.62, 50.57, 51.02, 51.58 (C, Met),
55.56, 55.71 (C, Phe), 78.05 (C, Boc), 93.52, 94.04 (C1,1',
Tre), 126.17 (C, Phe), 128.01 (C, Phe), 129.21 (C, Phe),
137.89, 138.20 (C, Phe), 155.06, 155.28 (CO, Boc), 171.80
(CO, Phe, Met). 1H NMR (DMSO-d6) /ppm 1.29 (45H,
CH3, Boc), 1.8–2.1 (10H, ,', Met), 2.0–2.07 (15H, S-CH3,
Met), 2.3–2.6 (10H, ,' Met), 2.75/2.96 (10H, ,', Phe),
3.15, 3.33, 3.52, 3.62, 3.80, 3.94, 4.10 (H, Tre), 4.19 (5H,
, Phe), 4.47 (5H, , Met), 6.7–6.9 (5H, NH, Phe), 7.18–
7.26 (25H, arom. H, Phe), 7.9–8.3 (5H, NH, Met). M.p.
105–113 °C; ESI-MS Calcd. for C107H152N10O31S5 2234.76.
Found: (M+Na)+ m/z 2256.8.
6,6'-Di-O-(Boc-Gly-Gly-)-,-trehalose (6)
13C NMR (DMSO-d6) /ppm 28.14 (CH3, Boc), 40.42,
43.00 (C, Gly1, Gly2), 77.97 (C, Boc), 155.70 (CO, Boc),
177.18 (CO, Gly1, Gly2); 1H NMR (DMSO-d6) /ppm 1.38
(18H, CH3, Boc), 3.35, 3.52, 3.58, 3.84 (8H, , Gly1,
Gly2) 7.05, 8.36 (4H, NH, Gly1, Gly2). 1H and 13C NMR
data for the trehalose moiety are presented in Tables I and
II. M.p. 175–185 °C; ESI-MS Calcd. for C30H50N4O19
770.31. Found: (M+Na)+ m/z 793.0, (M–H)– m/z 769.2.
2,2',6,6'-Tetra-O-(Boc-Gly-Gly-)-,-trehalose (7)
13C NMR (DMSO-d6) /ppm 28.12 (CH3, Boc), 40.39,
42.98 (C, Gly1, Gly2), 78.00 (C, Boc), 155.67 (CO, Boc),
169.38, 169.61, 169.67, 169.86 (CO, Gly1, Gly2); 1H NMR
(DMSO-d6) /ppm 1.38 (36H, CH3, Boc), 3.58, 3.85, 3.99
(16H, , Gly1, Gly2) 7.02, 8.18 (8H, NH, Gly1, Gly2). 1H
and 13C NMR data for the trehalose moiety are presented in
Tables I and II. M.p. 127–135 °C; ESI-MS Calcd. for
C48H78N8O27 1198.50. Found: (M+Na)+ m/z 1221.5, (M–H)–
m/z 1197.2.
2,2',3,6,6'-Penta-O-(Boc-Gly-Gly-)-,-trehalose (8)
13C NMR (DMSO-d6) /ppm 28.15 (CH3, Boc), 40.29, 43.01
(C, Gly1, Gly2), 78.06, 78.09 (C, Boc), 155.73 (CO, Boc),
169.62, 169.66, 170.20, 170.26 (CO, Gly1, Gly2); 1H NMR
(DMSO-d6) /ppm 1.37 (45H, CH3, Boc), 3.60, 3.86 (20H,
, Gly1, Gly2) 6.85, 7.00, 8.20 (10H, NH, Gly1, Gly2). 1H
and 13C NMR data for the trehalose moiety are presented in
Tables I and II. M.p. 120–128 °C; ESI-MS Calcd. for
C57H92N10O31 1412.59. Found: (M+Na)+ m/z 1435.5, (M–H)–
m/z 1411.2.
2,2',4,6,6'-Penta-O-(Boc-Gly-Gly-)-,-trehalose (9)
13C NMR (DMSO-d6) /ppm 28.19 (CH3, Boc), 43.02 (C,
Gly1, Gly2), 78.09, 78.19 (C, Boc), 155.77 (CO, Boc), 169.33,
169.49, 170.04, 170.32 (CO, Gly1, Gly2), 90.69, 91.09, 91.79
(C1,1', Tre), 72.48, 72.53, 72.80, 72.84 (C2,2', Tre), 67.12,
67.28, 69.80, 69.85, 69.92, 69.97, 70.29, 73.24, 73.50
(C3,3',4,4',5,5', Tre), 62.95, 63.47 (C6,6', Tre); 1H NMR
(DMSO-d6) /ppm 1.38 (45H, CH3, Boc), 3.60, 3.80, 3.85
(20H, , Gly1, Gly2), 4.20, 4.25 (4H, H6,6', Tre), 4.63,
4.86 (2H, H2,2', Tre), 3.73–5.50 (6H, H3,3',4,4',5,5', Tre),
5.01, 5.09 (2H, H1,1', Tre), 6.65, 7.00, 8.20 (10H, NH, Gly1,
Gly2). M.p. 115–123 °C; ESI-MS Calcd. for C57H92N10O31
1412.59. Found: (M+Na)+ m/z 1435.5, (M–H)– m/z 1411.2.
2,2',4,4,'6,6'-Hexa-O-(Boc-Gly-Gly-)-,-trehalose (10)
13C NMR (DMSO-d6) /ppm 28.15 (CH3, Boc), 40.29, 43.02
(C, Gly1, Gly2), 78.07 (C, Boc), 155.73 (CO, Boc), 169.42,
169.67, 169.97 (CO, Gly1, Gly2); 1H NMR (DMSO-d6)
/ppm 1.37 (54H, CH3, Boc), 3.56, 3.85, 3.95 (24H, ,
Gly1, Gly2) 6.99, 8.19 (12H, NH, Gly1, Gly2). 1H and 13C
NMR data for the trehalose moiety are presented in Tables I
and II. M.p. 145–155 °C; ESI-MS Calcd. for C66H106N12O35
1626.69. Found: (M+Na)+ m/z 1649.5, (M–H)– m/z 1625.3.
RESULTS AND DISCUSSION
Synthesis
As the starting carbohydrate material we utilized the sym-
metrical non-reducing disaccharide, ,-trehalose, which
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can be considered an anomerically protected D-glucose.
Esterification reactions were studied with either N-tert-
-butyloxycarbonyl-L-phenylalanyl-L-methionine (Boc-
Phe-Met-OH) or N-tert-butyloxycarbonyl-glycylglycine
(Boc-Gly-Gly-OH) by treating trehalose with the corre-
sponding dipeptide pentachlorophenyl ester, in the pres-
ence of imidazole as the promoting agent for transfer of
the acyl group to the sugar component.12,21 Pentachloro-
phenyl esters were chosen because a good leaving group
at the acyl donor is essential for efficient esterification,11
and this strategy should also allow comparison with pre-
viously published work on the synthesis of monosaccha-
ride esters.12 The molar proportions of the reactants used
were sugar:dipeptide:imidazole, 1:10:5, in all reactions
performed. The degree of substitution at the trehalose
moiety was shown to be very sensitive to the structure of
the starting dipeptide used in the esterification reaction.
In contrast to the regioselectivity observed previously
in the reaction of Boc-Phe-Leu-OPCP with unprotected
D-glucose,22 the esterification of trehalose with the acti-
vated dipeptide ester, Boc-Phe-Met-OPCP, afforded es-
ter derivatives 1–5 (Scheme 1). After purification by
column chromatography, the major product 6,6'-diester 1
was isolated in a 39 % yield, whereas the other products
were obtained in much lower yields. Esterification of the
secondary hydroxyl groups at the relatively small core
carbohydrate unit proceeded with difficulty, because the
disaccharide moiety becomes increasingly sterically hin-
dered as multiple esterification with the bulky dipeptide
moiety proceeds, and pentaacylated trehalose 5 was ob-
tained in very low yield (3 %). Another problem con-
nected with the esterification of sugars is acyl migra-
tion,23 which was particularly favored in the partially es-
terified trehalose products during purification on a silica
gel column. An additional problem was the separation of
isomeric esters, which was barely possible. The identity
and degree of acylation in esters 1-5 was confirmed by
NMR and MS analysis. The exact dipeptide group posi-
tion was confirmed by NMR only in 6,6'-diester 1 and
2,6,6'-triester 2, whereas NMR analysis of products 3–5
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Scheme 1.
indicated mixtures of numerous trehalose dipeptide iso-
mers. The chemical shift data in DMSO-d6 solution for
esters 1 and 2 are summarized in Tables I and II. It can
be presumed that asymmetrically substituted trehalose
esters, especially those with a low degree of substitution
(3 and 4), readily undergo acyl migration, a process fre-
quently observed during the synthesis and purification of
sugar esters.24
It can be expected that in addition to the differences
in reactivity of individual sugar hydroxyls, characteris-
tics of the acylating reagent also contribute to the distri-
bution of trehalose esters. To explore the influence of
peptidyl moiety bulkiness on the number and position of
trehalose hydroxyl group substitution, we decided to use
a sterically less demanding dipeptide. Thus, the penta-
chlorophenyl ester of N-tert-butyloxycarbonyl-glycyl-
glycine was reacted with ,-trehalose in the presence
of imidazole as a catalyst, using the same conditions as
described for Boc-Phe-Met-OH (Scheme 1). Compounds
6–10 were isolated from the reaction mixture and char-
acterized on the basis of NMR and MS studies. Compar-
ison of Boc-Gly-Gly-OH and Boc-Phe-Met-OH derived
trehalose esters (Scheme 1) points to significant differ-
ences in both the number and position of disaccharide
O-substitution. As expected, the compound with the
lowest degree of substitution is the one with the dipep-
tide moiety occupying the two primary hydroxyl groups
of the disaccharide molecule (compound 6, Scheme 1).
In contrast to Boc-Phe-Met-OH-derived trehalose esters,
the next higher substituted Boc-Gly-Gly-OH derived
trehalose ester was identified as tetrasubstituted ester 7.
Further, the next two trehalose esters were, based on NMR
and MS data, identified as pentasubstituted trehalose es-
ters 8 and 9. NMR data (further in text) point to 2,2',6,6'
substitution in both esters. The fifth site in compound 8
was confirmed to be the hydroxyl group at C3. In con-
trast to ester 8, the exact position of the fifth substitution
site in ester 9 could not be undoubtedly established by
NMR and MS data, but it can be presumed that com-
pound 9 is the 2,2',4,6,6'-pentaester. Finally, the highest
degree of substitution was found in compound 10, iden-
tified as 2,2',4,4',6,6'-hexaester. It should be underlined that
the relative distributions of the esters highly depend on the
work-up procedure. Yields presented in Scheme 1 were ob-
tained after purification by column chromatography, with-
out acidification and extraction. When aqueous work-up
is applied before column chromatography, the yield of
6,6' diester 6 is dramatically reduced (47 %  4 %) with
slightly increased yields of other higher substituted es-
ters, as a result of combined acyl migration and exten-
sive hydrolysis.
Comparison of compounds 1–5 with 6–10 revealed
distinct differences in both the number of dipeptide units
attached to the trehalose core and the position of substi-
tution. After substitution of the primary C66' hydroxyl
groups, the C2 position is the second site of choice. This
finding is in agreement with the higher reactivity of the
C2 hydroxyl group in the esterification reaction compar-
ed with other secondary groups, as observed in methyl
-D-glucopyranoside12 and 4,6:4',6'-di-O-benzylidene
,-trehalose.25 However, the symmetrical 2,2',6,6'-te-
trasubstituted trehalose ester was obtained with Boc-
Gly-Gly-OH (compound 7), while the asymmetrically
substituted 2,6,6'-triester 2 was isolated with Boc-Phe-
Met-OH. Considering trehalose symmetry and the prox-
imity of hydroxyls at C2 and C2', it is reasonable to pre-
sume that two peptides attached at the C2 and C2' posi-
tions will line up in the same direction close to each other.
This arrangement was achieved with Boc-Gly-Gly-OH;
however, no 2,2',6,6'-tetraester formation was observed
in the Boc-Phe-Met-OH line. These results suggest that,
in the latter case, acyl donor approach to the C2' position
is restrained by the sterically demanding dipeptide unit
already occupying the C2 position. The degree of substi-
tution in the other isolated esters is also in agreement
with the above-mentioned influence of acyl agent bulki-
ness. All trehalose esters obtained with Boc-Phe-Met-
OH are asymmetrically substituted (with the exception
of 1). In the Boc-Gly-Gly-OH line, however, acylation
of the two primary and two secondary hydroxyls still
leaves sufficient space for further substitutions and ends
up with the two pentasubstituted esters, 8 and 9. Further-
more, even hexasubstituted symmetrical ester 10 was iso-
lated, with dipeptide units occupying the 2,2',4,4',6,6'
hydroxyl positions. Although a large excess of the acyla-
ting reagent was applied, octasubstituted esters were not
formed with either of the dipeptides examined, demon-
strating that steric congestion leads to serious synthetic
problems even with small linear peptides. Since the same
molar proportions of reactants, the same solvent, acyl
acceptor (trehalose) and type of activated ester (penta-
chlorophenyl) are used with both dipeptides studied here,
it is reasonable to presume that the structure of the acy-
lation reagent directs the distribution of acylating prod-
ucts.
Enzymatic synthesis of sucrose and trehalose amino
acid esters revealed different acylation patterns for the
two disaccharides.9 While sucrose was acylated only at
one or two of the three primary hydroxyls, trehalose was
acylated at both primary (6,6'-OH) and only one second-
ary (3-OH) position. In contrast, chemical esterification
of sucrose in aqueous medium gave mono-, di-, tri- and
even higher substituted esters, depending on the reaction
conditions.24 Our previous study on the esterification
pathway of methyl--D-glucopyranoside under the same
conditions applied in the present work, showed that the
reactivity of the OH groups in this non-reducing sugar
decreases in the order 6-OH>2-OH>3-OH.12 In summary,
it can be concluded that the product distribution found
for trehalose-centered dipeptide esters is in accord with
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the results on hydroxyl group reactivity established for
methyl--D-glucopyranoside. However, lower regiose-
lectivity, resulting in a higher degree of substitution, was
observed than for the monosaccharide type esters.
The trehalose derivatives presented here can be con-
sidered templates of sugar-based modules for the study
of controlled delivery of bioactive components in vivo.
Namely, in therapeutic drug delivery, controlled drug re-
lease is of the utmost importance. Many studies have
shown that, among the carbohydrates usually used for
drug release, trehalose and its esters have superior stabi-
lizing properties compared to sucrose and especially glu-
cose.26,27 For further elongation of the peptide moieties
in the prepared trehalose derivatives, Boc removal is a
necessary step. In order to gain an insight into deprotec-
tion efficiency, we have performed deprotection of 6,6'-
di-O-(Boc-Gly-Gly-)-,-trehalose (6) in a TFA-water
(9:1) mixture, and we obtained 6,6'-di-O-(Gly-Gly-)-
,-trehalose in quantitative yield (data not shown).
However, some precautions are necessary, since it is
known that N-terminally deprotected dipeptide esters
readily undergo diketopiperazine formation.14,28,29 Thus,
the deprotection step is best performed immediately be-
fore the elongation step.
NMR Analysis of Trehalose Esters 1–10
The presence of peptide groups attached to trehalose hy-
droxyls results in a large number of protons in a rela-
tively narrow range of chemical shifts, difficulties being
more pronounced when moving from lower to higher
substituted trehalose derivatives.
Analysis of the 13C NMR spectra of compounds 1
and 6 and comparison with the spectrum of unsubstituted
trehalose revealed a downfield shift for the C66' carbons
(	 2.8 ppm, Table I) and an upfield shift for the C55'
carbons (	 3.7 ppm). In addition, the H66' protons were
also shifted to lower field (	 0.7 ppm) accompanied by a
smaller shift in the same direction (	 0.3 ppm) for the
neighboring H55' protons (Table II). Integration of the
dipeptide amide protons and comparison with suitable
well resolved trehalose protons gave a peptide:trehalose
ratio of 2:1. Taken together, these data allowed identifi-
cation of compounds 1 and 6 as 6,6'-diesters.
The NMR spectrum of trehalose ester 2 showed two
signals for the anomeric carbon atoms at 91.57 and
94.77 ppm (Table I) and downfield shifts for C2 as well
as for C66', indicating 2,6,6'-esterification of the trehalose
molecule. The large downfield shift for H2 (	 1.4 ppm),
while the chemical shift of H2' was unchanged, confirmed
the asymmetrical esterification with Boc-Phe-Met-OH in
compound 2.
The 1H and 13C NMR spectra of compounds 3–5 were
extremely complex, demonstrating that in trehalose par-
tially acylated with bulky Boc-Phe-Met-OH moieties, a
massive acyl migration occurred, giving rise to a mix-
ture of different isomers. The dipeptide to trehalose ratio
was determined for each compound from the 1H NMR
spectrum by comparing the amide protons with the well
resolved protons of the trehalose moiety. The 13C and 1H
NMR chemical shifts of esters 3–5 are given in the Ex-
perimental section.
Trehalose ester 7 was assigned based on COSY and
HMQC experiments. Close inspection of the anomeric re-
gion showed shifts of the C11' signals to higher field
(90.57 and 91.92 ppm, Table I) relative to both unsubsti-
tuted trehalose and diester 6, and at the same time shifts
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TABLE I. 13C NMR chemical shifts for the trehalose moiety in Boc-Phe-Met-OH derived esters (1, 2) and Boc-Gly-Gly-OH derived esters
(6, 7, 8 and 10)(a)
Carbon
atom
Trehalose 6,6'-diester
1
2,6,6'-triester
2
6,6'-diester
6
2,2',6,6'-
tetraester
7
2,2',3,6,6'-
pentaester
8
2,2',4,4',6,6'-
hexaester
10
C1
C1'
C2
C2'
C3
C3'
C4
C4'
C5
C5'
C6
C6'
93.53
93.53
72.03
72.03
72.90
72.90
70.52
70.52
73.31
73.31
61.17
61.17
93.68
93.68
71.31
71.31
72.62
72.62
70.04
70.04
69.61
69.61
64.02
64.02
91.57
94.77
73.74
71.54
69.92
73.16
70.58
70.58
70.22(b)
70.40(b)
64.11
64.11
93.43
93.43
71.66
71.66
72.46
72.46
70.16
70.16
69.61
69.61
63.95
63.95
90.57
91.92
73.52
73.52
70.27
70.30
69.78
69.78
69.88
69.88
63.23(b)
63.73(b)
91.23
91.43
70.28
72.75
72.67
69.76
67.11
69.83
69.94
69.94
62.78(b)
63.41(b)
91.22
90.58
73.18
73.18
69.86
70.28
72.73
72.73
69.77
69.77
63.40(b)
63.84(b)
(a) In DMSO-d6 at room temperature.
(b) Could be reversed.
of the C22' signals to lower field (73.52 ppm). Chemical
shifts of C55' and C66' are within the same region as found
for diester 6. The most important finding in the 1H NMR
spectrum of ester 7 is a large downfield shift for the H22'
protons (4.57 ppm) along with a small shift for the neigh-
boring protons (H11' and H33') in the same direction
(Table II). These data, together with the peptide:trehalose
4:1 ratio (based on integration) suggest that compound 7
is the 2,2',6,6'-tetrasubstituted trehalose ester.
Even at first sight, the 13C and 1H NMR spectra of
trehalose ester 8 differ from those of esters 6 and 7 by
the presence of two sets of resonances, particularly nota-
ble in the proton 1D and 2D spectra. Figure 1A shows
part of the COSY spectrum with designated key correla-
tions. The lower field anomeric proton (5.09 ppm, Table
II) shows a cross peak with the lower field H2 proton at
4.82 ppm, which is in correlation with the highly down-
field-shifted H3 at 5.25 ppm (dashed lines at Figure 1A).
Accordingly, the upper field anomeric proton at 5.01 ppm
correlates with the upper field H2' proton (4.60 ppm),
which shows correlation with H3' at 3.73 ppm (dotted
lines in Figure 1A). Chemical shifts of the H22' protons
are in agreement with O-substitution at positions 2 and
2', while the large downfield shift of H3 and the un-
changed chemical shift of H3' point to esterification at
the 3-position. Integration of the proton spectrum gave a
peptide:trehalose ratio of 5:1, which is in agreement with
2,2',3,6,6'-pentaester structure 8. Influence of asymmet-
ric substitution on the carbon chemical shifts of ester 8
can be easily followed by comparison with those of the
symmetrically substituted ester 7 (Table I). Substitution
at the 3-position caused a downfield shift for C3 (	 2.4
ppm) and accordingly 	 3.24 ppm and 	 2.67 ppm up-
field shifts for the adjacent C2 and C4.
Lack of sugar cross correlations in the 2D spectra of
trehalose ester 9 made it impossible to assign undoubt-
edly all proton and carbon resonances. However, com-
parison with the NMR data of other trehalose esters al-
lows us to speculate about its structure with a certain de-
gree of confidence. The anomeric region in the 1H
spectrum as well as the H22' protons show two distinct
sets of resonances, as seen in the spectra of ester 8. Inte-
gration of suitable, well resolved peaks gave a 5:1 pep-
tide:trehalose ratio. Chemical shifts of H2 and H2' at 4.86
and 4.63 ppm (see Experimental section) are in agree-
ment with substitution at positions 2 and 2'. Since the
fifth site of substitution in pentaester 8 is assigned to C3, it
is reasonable to deduce that compound 9 is a 2,2',4,6,6'-
pentaester.
A single set of resonances in the spectra of trehalose
ester 10 points to symmetrical distribution of dipeptide
units at the two trehalose rings (Figure 1B). The H22'
protons are found at 4.59 ppm and correlate with the H33'
protons at 3.80 and 3.70 ppm. Their correlation with
H44' at 5.34 and 5.31 ppm indicates that positions 4 and
4' are occupied by peptide moieties. Moreover, the H55'
protons, placed in-between two substituted sites, are also
shifted downfield and found at 4.82 and 4.84 ppm. The
peptide:trehalose ratio of 6:1 is in agreement with the
identification of 10 as a 2,2',4,4',6,6'-hexaester. In the
13C NMR spectrum, all carbons at substituent-bearing
positions are shifted downfield, while those nearby are
found at a higher field (Table I).
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TABLE II. 1H NMR chemical shifts for the trehalose moiety in Boc-Phe-Met-OH derived esters (1, 2) and Boc-Gly-Gly-OH derived esters
(6, 7, 8 and 10)(a)
Proton Trehalose 6,6'-diester
1
2,6,6'-triester
2
6,6'-diester
6
2,2',6,6'-
tetraester
7
2,2',3,6,6'-
pentaester
8
2,2',4,4'.6,6'
-hexaester
10
H1
H1'
H2
H2'
H3
H3'
H4
H4'
H5
H5'
H6
H6'
4.64
4.64
3.23
3.23
3.55
3.55
3.13
3.13
3.64
3.64
3.47/3.55
3.47/3.55
4.83
4.83
3.27
3.27
3.54
3.54
3.13
3.13
3.95
3.95
4.16
4.16
4.99
4.86
4.59
3.32
3.76
3.52
3.20
3.20
3.70
3.70
4.12/4.23
4.12/4.23
4.85
4.85
3.22
3.22
3.57
3.57
3.11
3.11
3.95
3.95
4.05/4.25
4.05/4.25
4.97
4.97
4.57
4.57
3.75
3.70
3.26
3.26
4.03
4.03
4.11/4.30
4.15/4.22
5.09
5.01
4.82
4.60
5.25
3.73
3.57
3.27
4.06
_(b)
4.16/4.30(c)
4.20/4.28(c)
4.97
4.99
4.59
4.59
3.80
3.70
5.34
5.31
4.82
4.84
4.14/4.28
4.14/4.28
(a) In DMSO-d6 at room temperature.
(b) Not assigned.
(c) Could be reversed.
MS Analysis of Trehalose Esters 1–10
Full scan mass spectra of all compounds were recorded
in positive and/or negative ion modes and were supple-
mented with MS/MS and MS3 spectra. In positive ion
mode, all compounds show pseudomolecular ions in the
form of sodium adducts, 
M+Na+, in agreement with
the calculated values. The mass spectra of trehalose es-
ters 2 and 3 in positive ion mode show identical values
for the pseudomolecular 
M+Na+ ions at m/z 1499, thus
confirming the structure with 3 dipeptide units attached to
the trehalose core. Since the structures of Boc-Gly-Gly-
OH derived trehalose esters were determined undoubt-
edly with respect to the number and position of substi-
tuted sites, their fragmentation behavior was studied in
more detail in order to explore the utility of mass spec-
trometry for the characterization of trehalose-related iso-
meric esters. In the case of trehalose ester 10, the
pseudomolecular ions obtained in positive and negative
ion modes are unstable and appear in very low intensi-
ties, thereby preventing further tandem mass spectromet-
ric studies.
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Figure 1. Part of the COSY spectra of (A) 2,2’,3,6,6’-pentaester 8 and (B) 2,2’,4,4’,6,6’-hexaester 10.
The MS/MS spectrum of the pseudomolecular

M+Na+ ion (m/z 793) of diester 6 shows two consecu-
tive losses of 100 Da fragments originating from the
cleavage of the (CH3)3COCO moiety from the N-termi-
nal part of the peptide (Figure 2A). The appearance of
the ion at m/z 299 can be explained by the cleavage of
the glycoside bond together with the 100 Da loss. At-
tempting to gain a closer insight into the fragmentation
of 6, we provide a collision-induced dissociation spec-
trum of the product ion at m/z 593, i.e., the MS3 spec-
trum of 6. Inspection of this spectrum suggests two frag-
mentation pathways. Loss of a dipeptide unit (114 Da)
gives rise to ion m/z 479 (Figure 2B), which undergoes
loss of a water molecule affording m/z 461, and further
CHOH loss (30 Da) to yield m/z 431. The most abundant
ion in the spectrum is m/z 317, resulting from cleavage
of the glycoside bond. This fragment acts as a precursor
of further consecutive losses of HOCHCHOH and two
CHOH units giving ions m/z 257, 227 and 197, respec-
tively (Figure 2C). All of these data are consistent with
the structure of 6,6'-diester 6.
Mass spectra in negative ion mode were taken at dif-
ferent collision energies (see Experimental section), but
generally the only difference can be seen in the intensi-
ties of certain fragment ions. The tandem mass spectrum
of the molecular 
M–H– ion of diester 6 at m/z 769
shows the most abundant ions at m/z 695 and 621, aris-
ing from the loss of a (CH3)3CO unit (74 Da) from the
Boc-peptide N-terminus (Figure 3). Consecutive losses
of two peptide chains (214 Da) give rise to low intensity
ions at m/z 555 and 341. Cleavage of a single peptide
moiety from the m/z 695 generates an ion at m/z 481,
which further undergoes losses of one and three water
molecules, to yield m/z 463 and 427, respectively. Also,
m/z 481 acts as a precursor of ions m/z 361 (120 Da, four
CHOH units) and m/z 301 resulting from the cleavage of
the glycoside bond.
The MS of tetraester 7 in positive ion mode shows
the pseudomolecular 
M+Na+ ion at m/z 1221, thus con-
firming the structure with 4 peptide units attached to the
trehalose core. MS/MS of the 
M+Na+ ion m/z 1221
shows only ions at m/z 1121, 1021, 921 and 821, arising
from consecutive losses of peptide chains, without any
additional structural information. In negative ion mode,
MS/MS of the molecular 
M–H– ion at m/z 1197 affords
a complex network of fragment ions arising from com-
bined losses of peptide moieties (214 Da), (CH3)3CO units
(74 Da), and water molecules. Unfortunately, tetraester 7
turned out to be quite unstable under the collision condi-
tions applied, which prevented a more detailed study of
its fragmentation pattern.
Pentasubstituted trehalose esters 8 and 9 have iden-
tical molecular masses and accordingly give pseudomo-
lecular 
M+Na+ ions at m/z 1435. Since MS/MS of m/z
1435 show only losses of (CH3)3COCO units (100 Da),
as seen with the previously mentioned esters, we attempt-
ed to get additional structural information by looking at
the fragmentation behavior of m/z 935, an ion obtained
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Figure 2. (A) Fragmentation of the pseudomolecular 
M+Na+ ion
m/z 793 of diester 6; (B) Fragmentation of the m/z 593 ion in the
MS3 of diester 6; (C) Structure and fragmentation of the m/z 317
ion in the MS3 of diester 6.
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Figure 3. Fragmentation of the molecular 
M–H– ion at m/z 769 of diester 6.
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Figure 4. Positive ion MS3 of the m/z 935 of pentaesters 8 and 9.
after cleavage of all five (CH3)3COCO moieties. MS3 of
the m/z 935 ions derived from trehalose ester 8 and 9 show
identical fragmentation patterns (Figure 4). In addition
to the low intensity ions m/z 878 and 746 corresponding
to the loss of glycine moieties (57 Da) from m/z 935 and
803, respectively, the remaining fragments arise from the
cleavage of the peptide (114 Da), CHOH moiety (30 Da)
and water (18 Da). In negative ion mode, MS/MS of the
molecular 
M–H– ion at m/z 1411 of both esters 8 and 9
revealed rich fragmentation patterns as observed with
ester 7, but without characteristic structural features.
CONCLUSIONS
The results presented here show that the biologically rel-
evant ,-trehalose can be subjected to successive che-
mical esterification reactions, acting as a multivalent core
acceptor. Reactions performed under identical conditions
(solvent, molar proportions of reactants, condensation
method) with two, in the sterical sense, differently de-
manding dipeptides, Boc-Phe-Met-OH and Boc-Gly-Gly-
OH, revealed the importance of the structure of the acy-
lating reagent for the pattern of trehalose esters. In both
lines, the 6,6'-diester was isolated in the highest yield.
However, with Boc-Phe-Met-OH, only asymmetrical
higher substituted esters were obtained; two triesters, a
tetra- and a pentaester. In contrast, in the Boc-Gly-Gly-
OH line, two symmetrical and two asymmetrical esters
were isolated. In all higher substituted esters within this
line, the C2, C2', C6 and C6' positions were occupied by
dipeptide moieties. Both 2,2',3,6,6'- and 2,2',4,6,6'-
pentaesters were isolated, in addition to the 2,2',4,4',6,6'-
hexaester. These data imply that, under the reaction condi-
tions applied, less bulky dipeptides are better arranged
around the trehalose core, allowing a higher degree of sub-
stitution. Also, extensive acyl migration, accompanied by
hydrolysis during aqueous work-up and chromatographic
separation, is to be taken into account when performing
esterification reactions under the described conditions.
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SA@ETAK
Sinteza dipeptidnih estera trehaloze
Ivanka Jeri}, Marko Mom~ilovi}, Igor Brato{ i [tefica Horvat
Kemijska esterifikacija ,-trehaloze s dva razli~ita dipeptidna acilna donora, Boc-Phe-Met-OH i Boc-
Gly-Gly-OH, dala je niz produkata koji se razlikuju u broju i polo`aju supstitucije. Oba kori{tena dipeptida
daju 6,6'-diestere kao glavne produkte. U slu~aju Boc-Phe-Met-OH dipeptida svi su vi{i supstituirani esteri
na|eni s nesimetri~nom raspodjelom dipeptidnih jedinica na dva trehalozna prstena. Nasuprot tomu, prvi vi{i
supstituirani ester Boc-Gly-Gly-OH simetri~ni je 2,2',6,6'-tetraester. Ta ~etiri polo`aja ostaju supstituirana u
svim ostalim izoliranim produktima, dvama nesimetri~nim pentaesterima i jednom simetri~nom heksaesteru.
Prikazani rezultati pokazuju da su osim reaktivnosti {e}ernih hidroksilnih skupina i karakteristike aciliraju}eg
reagensa, prvenstveno steri~ke, od izuzetnog zna~aja kod predvi|anja raspodjele acilnih skupina oko nereduci-
raju}e sredi{nje disaharidne molekule.
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